Khan Najat 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Recursion CEO Najat Khan Withholds 62,701 Shares for Taxes
What Happened Najat Khan, CEO, President and a director of Recursion Pharmaceuticals (RXRX), had 62,701 shares disposed on 2026-05-15 as shares withheld to satisfy tax withholding obligations related to a net settlement of restricted stock units. The shares were recorded at $3.04 each, for a notional value of $190,611. This was a withholding to cover taxes on RSUs rather than an open-market sale initiated by the insider.
Key Details
- Transaction date: 2026-05-15
- Shares withheld/disposed: 62,701 at $3.04 per share; total value ≈ $190,611
- Transaction code: F (payment of exercise price or tax liability / shares withheld)
- Footnote: Issuer withheld shares to satisfy its tax withholding and remittance obligations in connection with net settlement of restricted stock units (per F1)
- Filing date (Form 4): 2026-05-19
- Shares owned after transaction: Not specified in the provided filing
Context This was a routine tax-withholding/net-settlement of RSUs, commonly done by the company withholding a portion of vested shares to cover required taxes. Such transactions do not necessarily reflect the insider’s view on the company’s stock price because no open-market selling by the insider occurred.
Insider Transaction Report
- Tax Payment
Class A Common Stock
[F1]2026-05-15$3.04/sh−62,701$190,611→ 2,199,384 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.